Los Angeles/Desert Hot Springs, CA, Aug. 05, 2019 (GLOBE NEWSWIRE) — Imaging3, Inc./Grapefruit (IGNG), (“Grapefruit” or the “Company”) announces that the week of August five, 2019, Grapefruit is launching its one of a kind line of newly formulated and flavored cannabis oil infused CDB and THC vaporization cartridges. Grapefruit utilizes only the most trusted oils and higher high-quality genuine CCELL ceramic vaporizer cartridges for its goods to assure the most constant and smooth solution delivery obtainable in the sector right now. The Rainbow Dreams branded CBD and THC vaporization cartridge line incorporates a formulated CBD heavy three:1 vaporization cartridge for buyers that want discomfort relief, but want to be only minimally impacted by THC. The 4 (four) new Grapefruit Rainbow Dream vape cartridges will each and every have its personal one of a kind flavor profile from mango passion to citrus bliss, and each and every flavor is paired to a complimentary cannabis strain which includes Durban Poison, Cannatonic and OG Kush.
Bradley J. Yourist, IGNG/Grapefruit’s CEO stated, “Moving the Rainbow Dreams project forward demonstrates our team’s potential to bring a higher high-quality solution to industry at a competitive value with strong margins for Grapefruit and its retailers. Flavored and complete spectrum cannabis oils, which includes reside resin are increasing in reputation in California and elsewhere for the reason that buyers in the recreational industry want a no burn-flavored oil without the need of any offending cannabis smell. Our Rainbow Dreams goods provide on this. Grapefruit, amongst its lots of other skills has the knowledge to formulate such flavored and infused oils to meet our customer’s existing demands. It is our expertise that some buyers like a much more CBD and CBN heavy formulated oil for enable with discomfort and sleep and are not interested in becoming maximally impacted in some situations. Our three:1 CBD vaporization carts, with a mango passion flavor profile, fill that ever increasing demand for CBD heavy goods. We also have a day-time sativa blended oil for these recreational customers that have an active way of life. Rainbow Dreams will also be the flagship for Grapefruit’s new edibles cued-up to be launched in the subsequent 45 days. By implementing our personal higher-finish, custom formulated vaporization cartridge line, Grapefruit believes it will capture substantial income possibilities as we move inexorably toward our objective of becoming a top totally integrated, licensed and compliant cannabis solution manufacturing and distribution organization.”
Grapefruit’s corporate headquarters is situated in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to each manufacture and distribute cannabis goods. Grapefruit’s cannabis and CBD extraction laboratory and distribution facilities are situated in the sector – recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Enterprise Park in Desert Hot Springs, situated on the extension of North Canyon Rd., roughly 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January of 2018 and commenced distribution of cannabis goods thereafter. Grapefruit’s vision is to grow to be a seed to sale, totally vertically integrated ethical and compliant cannabis and CBD solution Enterprise.
To receive additional details on Grapefruit and its operations, please pay a visit to its web site at https://grapefruitblvd.com/. To study much more about Grapefruit’s Sugar Stoned branded line of cannabis and CBD infused edibles, please pay a visit to us at https://sugarstoned.com/.
Secure Harbor Statement
Imaging3 cautions you that any statement incorporated in this press release that is not a description of historical information is a forward-hunting statement. A lot of of these forward-hunting statements include the words “anticipate,” “think,” “estimate,” “may perhaps” “intend,” “anticipate” and equivalent expressions. Actual benefits, efficiency or achievements could differ materially from these contemplated, expressed or implied by the forward-hunting statements contained herein. These forward-hunting statements are primarily based largely on the expectations of the organization and are topic to a quantity of dangers and uncertainties inherent in the Imaging3’s business enterprise, which includes, without the need of limitation: the organization may perhaps not ever receive FDA approval for any of its devices the organization may perhaps not be in a position to safe the funds required to help its solution improvement plans and the organization may perhaps not ever obtain the industry results to sustain a lucrative business enterprise. In addition, there are dangers and uncertainties connected to financial recession or terrorist actions, competitors from a lot bigger imaging firms, technological obsolescence, unexpected fees and delays, prospective solution liability claims, and lots of other components. Far more detailed details about Imaging3 and the threat components that may perhaps impact the realization of forward-hunting statements is set forth in the company’s filings with the Securities and Exchange Commission, which includes the company’s Annual Report on Kind 10-K and its Quarterly Report on Kind 10-Q. Such documents may perhaps be study totally free of charge on the SEC’s web site at www.sec.gov. You are cautioned not to spot undue reliance on these forward-hunting statements, which speak only as of the date hereof. All forward-hunting statements are certified in their entirety by this cautionary statement, and Imaging3 undertakes no obligation to revise or update this press release to reflect events or situations immediately after the date hereof. This caution is produced beneath the secure harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.